Phibro Animal Health | PAHC - Despesa De Juros Sobre A Dívida

Preço das Ações
40.00
Mudança Diária
-3.16 -7.32%
Mensal
-32.31%
Anual
78.02%
Q2 Previsão
39.17




Despesa De Juros Sobre A Dívida Alterar Data
Align Technology USD 16.04M 14.04M 2025-12
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Assertio Holdings USD 758K 1000 2024-06
Aurora Cannabis CAD 2.11M 116K 2025-12
Bristol-Myers Squibb USD 411M 21M 2026-03
Canopy Growth CAD 7.34M 1.46M 2025-12
Corcept Therapeutics USD 814.88M 809.46M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
Henry Schein USD 39M 0 2026-03
Idexx Laboratories USD 7.74M 2.34M 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Merck USD 479M 67M 2026-03
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Pacira USD 3.7M 193K 2026-03
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Supernus Pharmaceuticals USD 910K 278K 2023-06
Zoetis USD 62M 5M 2026-03